A single-cell derived spheroid approach to dissect intratumoural heterogeneity in colorectal cancer: cell lines show changes in proteomes and therapeutic response to 5-FU
Authors:
Open Access
- 24 January 2026
- journal article
- research article
- Published by Springer Nature in Journal of Cancer Research and Clinical Oncology
- Vol. 152 (1) , 43
Abstract
Purpose: Colorectal cancer (CRC) stands as a significant contributor to cancer-related mortality. Owing to its prognostic and therapeutic implications, intratumoural heterogeneity (ITH) presents a considerable challenge. We have developed an experimental framework integrating single-cell derived spheroids with proteomic profiling to facilitate a molecular, proteomic, and therapeutic characterization of intratumoural heterogeneity during CRC progression. Methods: Single cells from the commercially available colorectal cancer cell lines SW480 (primary colorectal adenocarcinoma) and SW620 (locoregional lymph node metastasis of the same donor) were isolated using fluorescence-activated cell sorting (FACS) and subsequently cultured forming spheroids. This platform allowed controlled interrogation of clonal diversity through proliferation and viability assays, alongside deep proteomic characterization using label-free liquid chromatography–mass spectrometry (LC-MS) with data-independent acquisition. To evaluate its utility for therapeutic testing, chemotherapy response was measured after 72 h of incubation with 5-fluorouracil (5-FU). Results: The single-cell derived spheroid system demonstrated significant heterogeneity, as evidenced by variations in morphology, growth dynamics, viability, and proteomic signatures. Protein profiling identified ITH-associated proteins (WDR5, CKB, IPO11, ATP6V1F, DCXR and PCCB) and underscored pathway variations including tumour suppressor and proto-oncogenic signalling, vascularization and metabolic regulation. Furthermore, individual spheroids exhibited differential sensitivities to 5-fluorouracil, demonstrating the platform’s capacity to resolve heterogeneous therapeutic responses. Conclusion: Our study establishes a robust and scalable method that integrates single-cell spheroids with proteomics to model and quantify ITH in CRC. By capturing clinically relevant diversity across morphology, viability, proteomic profiles and drug response, this approach provides a foundation for translating spheroid- and proteomics-based assays into personalized therapeutic testing.Keywords
Funding Information
- Universität zu Lübeck
This publication has 61 references indexed in Scilit:
- A Perspective on Cancer Cell MetastasisScience, 2011
- STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effectBMC Medicine, 2009
- Hormesis and medicineBritish Journal of Clinical Pharmacology, 2008
- MLL translocations, histone modifications and leukaemia stem-cell developmentNature Reviews Cancer, 2007
- Altered Expression and Localization of Creatine Kinase B, Heterogeneous Nuclear Ribonucleoprotein F, and High Mobility Group Box 1 Protein in the Nuclear Matrix Associated with Colon CancerCancer Research, 2006
- Characterization of Four Variant Forms of Human Propionyl-CoA Carboxylase Expressed in Escherichia coliJournal of Biological Chemistry, 2005
- Molecular mechanisms of drug resistanceThe Journal of Pathology, 2005
- Determination of the catalytic site of creatine kinase by site-directed mutagenesisBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1994
- Isolation and characterization of a highly malignant variant of the SW480 human colon cancer cell line.1992
- Isolation and characterization of propionyl-CoA carboxylase from normal human liver. Evidence for a protomeric tetramer of nonidentical subunits.Journal of Biological Chemistry, 1980